Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HCAR Stock Summary
In the News
HCAR Financial details
Company Rating
Neutral
Market Cap
418.14M
Income
14.98M
Revenue
0
Book val./share
-0.41
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
29 Mar 2021
P/E
27.3
Forward P/E
-
PEG
-0.02
P/S
-
P/B
-24.71
P/C
-
P/FCF
-352.73
Quick Ratio
0.13
Current Ratio
0.3
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.36
EPS next Y
-
EPS next Q
-
EPS this Y
-8766.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-53.08%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
4%
ROE
-69%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
33.12M
Shs Float
30.05M
-
-
-
-
Target Price
-
52W Range
9.7099-10.11
52W High
-100%
52W Low
-100%
RSI
0.5
Rel Volume
-
Avg Volume
140.71K
Volume
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 4.86%
Prev Close
-
Price
0
Change
-
HCAR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2021-12-31 |
---|---|---|
Revenue per share | 0 | |
Net income per share | 0.26 | |
Operating cash flow per share | -0.02 | |
Free cash flow per share | -0.02 | |
Cash per share | 0.02 | |
Book value per share | -0.66 | |
Tangible book value per share | 7.34 | |
Share holders equity per share | -0.66 | |
Interest debt per share | 0 | |
Market cap | 402.53M | |
Enterprise value | 401.79M | |
P/E ratio | 37.92 | |
Price to sales ratio | 0 | |
POCF ratio | -443.07 | |
PFCF ratio | -443.07 | |
P/B Ratio | -14.7 | |
PTB ratio | -14.7 | |
EV to sales | 0 | |
Enterprise value over EBITDA | 0 | |
EV to operating cash flow | -442.25 | |
EV to free cash flow | -442.25 | |
Earnings yield | 0.03 | |
Free cash flow yield | 0 | |
Debt to equity | 0 | |
Debt to assets | 0.09 | |
Net debt to EBITDA | 0 | |
Current ratio | 4.19 | |
Interest coverage | 0 | |
Income quality | -0.09 | |
Dividend Yield | 0 | |
Payout ratio | 0 | |
Sales general and administrative to revenue | 0 | |
Research and developement to revenue | 0 | |
Intangibles to total assets | 0 | |
Capex to operating cash flow | 0 | |
Capex to revenue | 0 | |
Capex to depreciation | 0 | |
Stock based compensation to revenue | 0 | |
Graham number | 1.95 | |
ROIC | -0.01 | |
Return on tangible assets | 0.03 | |
Graham Net | -0.67 | |
Working capital | 743.82K | |
Tangible asset value | 0 | |
Net current asset value | -27.45M | |
Invested capital | 0 | |
Average receivables | 0 | |
Average payables | 40.45K | |
Average inventory | 0 | |
Days sales outstanding | 0 | |
Days payables outstanding | 0 | |
Days of inventory on hand | 0 | |
Receivables turnover | 0 | |
Payables turnover | 0 | |
Inventory turnover | 0 | |
ROE | -0.39 | |
Capex per share | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.11 | 0.08 | 0.09 | 0.13 | 0.06 | |
Operating cash flow per share | 0 | -0.01 | -0.01 | -0.01 | 0 | |
Free cash flow per share | 0 | -0.01 | -0.01 | -0.01 | 0 | |
Cash per share | 0.01 | 0.02 | 0.01 | 0.01 | 0 | |
Book value per share | -0.74 | -0.66 | -0.57 | -0.45 | -0.41 | |
Tangible book value per share | 7.26 | 7.34 | 7.43 | 7.56 | 7.62 | |
Share holders equity per share | -0.74 | -0.66 | -0.57 | -0.45 | -0.41 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 403.65M | 404.06M | 405.72M | 407.38M | 411.1M | |
Enterprise value | 403.23M | 403.32M | 405.4M | 407.09M | 411.03M | |
P/E ratio | 21.35 | 29.82 | 27.61 | 18.9 | 40.67 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.6K | -1.38K | -920.61 | -1.66K | -1.99K | |
PFCF ratio | -2.6K | -1.38K | -920.61 | -1.66K | -1.99K | |
P/B Ratio | -13.12 | -14.76 | -17.11 | -22.05 | -24.29 | |
PTB ratio | -13.12 | -14.76 | -17.11 | -22.05 | -24.29 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 85.32 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | -2.6K | -1.38K | -919.87 | -1.66K | -1.99K | |
EV to free cash flow | -2.6K | -1.38K | -919.87 | -1.66K | -1.99K | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0.09 | 0.09 | 0.07 | 0.06 | 0.05 | |
Net debt to EBITDA | -0.09 | 0 | 0 | 0 | 0 | |
Current ratio | 2.69 | 4.19 | 2.83 | 2.23 | 0.3 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | -0.03 | -0.09 | -0.12 | -0.05 | -0.08 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.38 | 1.1 | 1.07 | 1.14 | 0.75 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
Graham Net | -0.75 | -0.67 | -0.58 | -0.46 | -0.43 | |
Working capital | 453.9K | 743.82K | 394.7K | 262.04K | -408.29K | |
Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
Net current asset value | -30.81M | -27.45M | -23.8M | -18.69M | -17.56M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 83.94K | 85.11K | 85.5K | 98.13K | 70.93K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.15 | -0.12 | -0.15 | -0.29 | -0.15 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
HCAR Frequently Asked Questions
What is Healthcare Services Acquisition Corporation stock symbol ?
Healthcare Services Acquisition Corporation is a US stock , located in Bethesda of Md and trading under the symbol HCAR
Is Healthcare Services Acquisition Corporation stock public?
Yes, Healthcare Services Acquisition Corporation is a publicly traded company.